Adrian Gottschalk - Apr 25, 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Adrian Gottschalk
Stock symbol
FHTX
Transactions as of
Apr 25, 2025
Transactions value $
$0
Form type
4
Date filed
4/28/2025, 04:01 PM
Previous filing
Apr 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Gift $0 -300K -36.96% $0.00 512K Apr 25, 2025 See Footnote F1, F2
transaction FHTX Common Stock Gift $0 +300K +141.71% $0.00 512K Apr 25, 2025 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 25, 2025, the Adrian H. Gottschalk Living Trust dated September 8, 2009 (the "Gottschalk Living Trust"), of which the Reporting Person is the trustee, distributed 300,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025 (the "Gottschalk 2025 GRAT"), of which the Reporting Person is the trustee and sole current beneficiary.
F2 Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust.